Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 103, Issue 2, 2011, Pages 148-151

  Chun, Jae Min ^a   Kwon, Hyung Jun ^a   Sohn, Junho ^a   Kim, Sang Geol ^a   Park, Ji Young ^a   Bae, Han Ik ^a   Yun, Young Kook ^a   Hwang, Yoon Jin ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

macroscopic vascular invasion; preoperative serum CRP; survival after early recurrence

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RISK FACTOR; TUMOR VOLUME; UNIVERSITY HOSPITAL;

C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79251527891     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21786     Document Type: Article

References (20)

1. Fan ST, Lo CM, Liu CL, et al.: Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths. Ann Surg 1999; 229: 322-330.
2. Imamura H, Shimada R, Kubota M, et al.: Preoperative portal vein embolization: An audit of 84 patients. Hepatology 1999; 29: 1099-1105.
3. Belghiti J, Panis Y, Farges O, et al.: Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-117.
4. Poon RT, Fan ST, Ng IO, et al.: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-507.
5. Portolani N, Coniglio A, Ghidoni S, et al.: Early and late recurrence after liver resection for hepatocellular carcinoma: Prognostic and therapeutic implications. Ann Surg 2006; 243: 229-235.
6. Shah SA, Greig PD, Gallinger S, et al.: Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006; 202: 275-283.
7. Imamura H, Matsuyama Y, Tanaka E, et al.: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207.
8. Cucchetti A, Piscaglia F, Caturelli E, et al.: Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol 2009; 16: 413-422.
9. Hermanek PHD, Hutter R, et al.: International Union Against Cancer [TNM Supplement 1993]: A Commentary on Uniform Use. Berlin: Springer; 1993; p. 7.
10. Yamanaka N, Okamoto E, Fujihara S, et al.: Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection ? Cancer 1992; 70: 2263-2267.
11. Regimbeau JM, Abdalla EK, Vauthey JN, et al.: Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study. J Surg Oncol 2004; 85: 36-41.
12. Terpos E, Szydlo R, Apperley JF, et al.: Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: Proposal for a novel prognostic index. Blood 2003; 102: 1064-1069.
13. Hefler LA, Concin N, Hofstetter G, et al.: Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 2008; 14: 710-714.
14. Nozoe T, Matsumata T, Kitamura M, et al.: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998; 176: 335-338.
15. Shimada H, Nabeya Y, Okazumi S, et al.: Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 2003; 83: 248-252.
16. Lin ZY, Wang LY, Yu ML, et al.: Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis. J Gastroenterol Hepatol 2000; 15: 417-421.
17. Hashimoto K, Ikeda Y, Korenaga D, et al.: The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005; 103: 1856-1864.
18. Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
19. Kamiyama T, Nakanishi K, Yokoo H, et al.: Recurrence patterns after hepatectomy of hepatocellular carcinoma: Implication of Milan criteria utilization. Ann Surg Oncol 2009; 16: 1560-1571.
20. Facciuto ME, Koneru B, Rocca JP, et al.: Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Ann Surg Oncol 2008; 15: 1383-1391.